Raphaella Wai Lam So, Hoi Shan Wong, Kam Ming Ko^*

Show more
Division of Life Science, Hong Kong University of Science & Technology, Hong Kong, China.
Show less

Abstract: Depression is a prevalent mental illness in developed countries. In Western medicine, experimental and clinical investigations have demonstrated that depression is associated with the dysregulation of neurotransmitter signaling, and symptoms of depression can be alleviated by therapeutic intervention. However, patients taking antidepressant drugs often experience serious side effects and high relapse rates. On the other hand, traditional Chinese medicine (TCM) views depression as a manifestation of liver qi stagnation. Practitioners of TCM have long been treating depression with herbs that promote qi circulation in the liver. In this article, we offer a hypothesis stating the biochemical basis of the linkage between liver qi stagnation and depression. Liver qi is involved in the processing of macronutrients into molecules to fuel energy metabolism in brain neurons, as well as the synthesis of plasma proteins that maintain blood circulation to the brain, thereby enabling these fuel molecules to be delivered to the brain. In cases of liver qi stagnation, the failure in delivering sufficient fuel molecules to the brain disrupts mitochondrial ATP production in neurons. Because neurotransmitter release and neurotropin transport are driven by ATP, the deficiency in release and transport processes resulting from insufficient ATP production could lead to depression. Therefore, if liver qi stagnation is causally related to the pathogenesis of depression, the promotion of liver qi circulation by Chinese herbs might offer a promising prospect for the effective treatment of depression.

Keywords: Mitochondrial ATP, Liver “Qi” Stagnation, Depression, Traditional Chinese Medicine

Cite this paper: Lam So, R. , Wong, H. and Ko, K. (2015) A Traditional Chinese Medicine Approach in Treating Depression by Promoting Liver Qi Circulation: A Western Medicine Perspective. Chinese Medicine, 6, 187-195. doi: 10.4236/cm.2015.64021.

References

[1]   World Health Organization (2012) Depression Fact Sheet.
http://www.who.int/mediacentre/factsheets/fs369/en/

[2]   Lee, S., Tsang, A. and Kwok, K. (2007) Twelve-Month Prevalence, Correlates, and Treatment Preference of Adults with DSM-IV Major Depressive Episode in Hong Kong. Journal of Affective Disorders, 98, 129-136.
http://dx.doi.org/10.1016/j.jad.2006.07.009

[3]   National Collaborating Centre for Mental Health (UK) (2010) Depression: The Treatment and Management of Depression in Adults. National Institute for Health and Clinical Excellence: Guidance, The British Psychological Society & The Royal College of Psychiatrists, Leicester.

[4]   Bayat, N., Alishiri, G.H., Salimzadeh, A., Izadi, M., Saleh, D.K., Lankarani, M.M. and Assari, S. (2011) Symptoms of anxiety and Depression: A Comparison among Patients with Different Chronic Conditions. Journal of Research in Medical Sciences, 16, 1441-1447.

[5]   Hasler, G. (2010) Pathophysiology of Depression: Do We Have Any Solid Evidence of Interest to Clinicians? World Psychiatry, 9, 155-161.
http://dx.doi.org/10.1002/j.2051-5545.2010.tb00298.x

[6]   Holsboer, F. and Ising, M. (2010) Stress Hormone Regulation: Biological Role and Translation into Therapy. Annual Review of Psychology, 61, 81-109.
http://dx.doi.org/10.1146/annurev.psych.093008.100321

[7]   Werner, F.M. and Coveñas, R. (2010) Classical Neurotransmitters and Neuropeptides Involved in Major Depression: A Review. International Journal of Neuroscience, 120, 455-470.
http://dx.doi.org/10.3109/00207454.2010.483651

[8]   Leonard, B.E. (2010) The Concept of Depression as a Dysfunction of the Immune System. Current Immunology Reviews, 6, 205-212.
http://dx.doi.org/10.2174/157339510791823835

[9]   Zunszain, P.A., Anacker, C., Cattaneo, A., Carvalho, L.A. and Pariante, C.M. (2011) Glucocorticoids, Cytokines and Brain Abnormalities in Depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 722-729.
http://dx.doi.org/10.1016/j.pnpbp.2010.04.011

[10]   Medscape (2014) Monoamine Oxidase Inhibitor Toxicity.
http://emedicine.medscape.com/article/815695-overview

[11]   Kong, L.D., Cheng, C.H.K. and Tan, R.X. (2001) Monoamine Oxidase Inhibitors from Rhizoma of Coptis chinensis. Planta Medica, 67, 75-76.
http://dx.doi.org/10.1055/s-2001-10874

[12]   Reeves, R.R. and Ladner, M.E. (2010) Antidepressant-Induced Suicidality: An Update. CNS Neuroscience & Therapeutics, 16, 227-234.
http://dx.doi.org/10.1111/j.1755-5949.2010.00160.x

[13]   DuRubeis, R.J., Siegle, G.J. and Hollon, S.D. (2008) Cognitive Therapy versus Medication for Depression: Treatment Outcomes and Neural Mechanisms. Nature Reviews Neuroscience, 9, 788-796.
http://dx.doi.org/10.1038/nrn2345

[14]   Kong, Y.C. (2005) The Cultural Fabric of Chinese Medicine: How to Know Your Body through Chinese Medicine. The Commercial Press, Hong Kong.

[15]   Tsim, K.W.K. (2015) The Genesis of Traditional Chinese Medicine, “The Divine Farmer’s Herb-Root Classic”.
http://www.master-insight.com/content/article/2911

[16]   Hong, H. (2014) The Theory of Chinese Medicine: A Modern Interpretation. Imperial College Press, London.
http://dx.doi.org/10.1142/p933

[17]   Levine, R.L., Fredericks, W.R. and Rapoport, S.I. (1982) Entry of Bilirubin into the Brain Due to Opening of the Blood-Brain Barrier. Pediatrics, 69, 255-259.

[18]   Kim, S.H., Han, J., Seog, D.H., Chung, J.Y., Kim, N., Park, Y.H. and Lee, S.K. (2005) Antidepressant Effect of Chaihu-Shugan-San Extract and Its Constituents in Rat Models of Depression. Life Sciences, 76, 1297-1306.
http://dx.doi.org/10.1016/j.lfs.2004.10.022

[19]   Liu, Y., Ma, S. and Qu, R. (2010) SCLM, Total Saponins Extracted from Chaihu-jia-longgu-muli-tang, Reduced Chronic Mild Stress-Induced Apoptosis in the Hippocampus in Mice. Pharmaceutical Biology, 48, 840-848.
http://dx.doi.org/10.3109/13880200903296154

[20]   Qiu, J., Hu, S.Y., Zhang, C.H., Shi, G.Q., Wang, S.E. and Xiang, T. (2014) The Effect of Chaihu-Shugan-San and Its Components on the Expression of ERK5 in the Hippocampus of Depressed Rats. Journal of Ethnopharmacology, 152, 320-326.
http://dx.doi.org/10.1016/j.jep.2014.01.004

[21]   Mizoguchi, K., Yuzurihara, M., Ishige, A., Aburada, M. and Tabira, T. (2003) Saiko-ka-ryukotsu-borei-to, a Herbal Medicine, Ameliorates Chronic Stress-Induced Depressive State in Rotarod Performance. Pharmacology Biochemistry & Behavior, 75, 419-425.
http://dx.doi.org/10.1016/s0091-3057(03)00131-x

[22]   Mizoguchi, K., Yuzurihara, M., Ishige, A., Sasaki, H. and Tabira, T. (2002) Saiko-ka-ryukotsu-borei-to, a Herbal Medicine, Prevents Chronic Stress-Induced Disruption of Glucocorticoid Negative Feedback in Rats. Life Sciences, 72, 67-77.
http://dx.doi.org/10.1016/S0024-3205(02)02199-9

[23]   Tamano, H. and Takeda, A. (2004) Suppressive Effect of Saiko-ka-ryukotsu-borei-to, a Herbal Medicine, on Excessive Release of Glutamate in the Hippocampus. Brain Research Bulletin, 64, 273-277.
http://dx.doi.org/10.1016/j.brainresbull.2004.07.013

[24]   Martinou, J.C. and Youle, R.J. (2011) Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics. Developmental Cell, 21, 92-101.
http://dx.doi.org/10.1016/j.devcel.2011.06.017

[25]   Morel, N. (2003) Neurotransmitter Release: The Dark Side of the Vacuolar-H+ ATPase. Biology of the Cell, 95, 453-457.
http://dx.doi.org/10.1016/S0248-4900(03)00075-3

[26]   Chen, Y.A. and Scheller, R.H. (2001) SNARE-Mediated Membrane Fusion. Nature Reviews Molecular Cell Biology, 2, 98-106.
http://dx.doi.org/10.1038/35052017

[27]   Cosker, K.E., Courchesne, S.L. and Segal, R.A. (2008) Action in the Axon: Generation and Transport of Signaling Endosomes. Current Opinion in Neurobiology, 18, 270-275.
http://dx.doi.org/10.1016/j.conb.2008.08.005